Only a small number of new antibiotics have been developed over the past few decades due to the cost and time associated with screening them. In fact, most newly approved antibiotics are simply minor variants of existing drugs. But now thanks to the power of artificial intelligence and the growing...
from TechSpot
Read The Rest:techspot...
No comments:
Post a Comment